Australia markets close in 1 hour 22 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1500-0.0500 (-4.17%)
At close: 04:00PM EST
1.1501 +0.00 (+0.01%)
After hours: 07:09PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.2000
Open1.2000
Bid1.1400 x 3200
Ask1.2100 x 800
Day's range1.1301 - 1.2100
52-week range1.1301 - 7.5500
Volume722,073
Avg. volume594,601
Market cap36.121M
Beta (5Y monthly)1.77
PE ratio (TTM)N/A
EPS (TTM)-3.0550
Earnings date12 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend date20 Aug 2015
1y target est11.67
  • GlobeNewswire

    Catalyst Biosciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that members of its executive management team will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, being held November 29-December 2, 2021. The fireside chat will be available on-demand for registered attendees via the Piper Sandler conference site beginning Monday, November 22, 2021 at 10:00 am ET until the end of the conference

  • GlobeNewswire

    Catalyst Biosciences Announces Change in Corporate Strategy

    Reports Third Quarter 2021 Operating & Financial ResultsCompany to discontinue MarzAA development; focus on developing its complement portfolio Management to host a call today at 8:30 am ET SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced a strategic decision to halt the clinical development of MarzAA, report data to date, and seek a buyer for its hemophilia assets. Catalyst plans to focus its resources on its complement the